| Literature DB >> 35078434 |
Shinichi Watanabe1,2, Yu Inami3,4, Hiroshi Kimura3,5, Takaaki Yano3,5, Masafumi Ono3,6, Ryosuke Akizuki3,7, Yukihiro Nawata3, Tomomi Tanaka3,8, Kiyoshi Furukawa3,8, Mamoru Tanaka3,5,8.
Abstract
BACKGROUND: Coronavirus disease 2019 (COVID-19) has heavily affected the economy, industries, and medicine. Local governments and medical institutions have struggled to respond. The purpose of this questionnaire survey was to evaluate strategies for pharmacy services, availability of ethanol for disinfection, and measures adopted for in-house infection control aiming to enhance future infection control efforts.Entities:
Keywords: COVID-19; Coronavirus; Disinfection; Ethanol; Infection control; Personal protective equipment; Pharmaceutical preparations; Pharmacy; Physical distancing; Surveys and questionnaires
Mesh:
Year: 2022 PMID: 35078434 PMCID: PMC8787450 DOI: 10.1186/s12889-022-12589-z
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Fig. 1Survey questionnaire. COVID-19, coronavirus 2019
Fig. 2a. Measures related to facilities and equipment. b. Personal protective equipment procured by pharmacy. c. Measures resulting in the procurement of ethanol for disinfection
Availability of ethanol for disinfection and other disinfectants
| No. of responses (%) | |
|---|---|
| Not affected | 11 (6.3) |
| Affected, but without detrimental effects on services or infection control | 142 (81.6) |
| Affected, with detrimental effects on some services and infection control | 19 (10.9) |
| Affected, with major detrimental effects on services and infection control | 2 (1.1) |
n = 174
Fig. 3a. Measures related to waiting patients. b. Measures related to dispensing medication and others
Consultation with a prescribing physician in a medical institution if a pharmacy staff member becomes infected
| No. of responses (%) | |
|---|---|
| Consultation with a prescribing physician in a medical institution | 26 (14.9) |
| No Consultation | 148 (85.1) |
n = 174
Fig. 4a. Meetings and others with external vendors. b. Meetings/conferences held within pharmacy (or corporate group). c. Measures related to staff break areas
Fig. 5Activities undertaken as part of COVID-19 infection control measures. COVID-19, coronavirus 2019
Sources of information used for COVID-19 measures and their usefulness
| Source of information | No. of responses | Usefulness |
|---|---|---|
| Television and other media | 116 | 3.59 |
| Japan Ministry of Health, Labour, and Welfare website | 140 | 4.03 |
| Cabinet Secretariat website | 25 | 3.92 |
| Ehime prefecture website | 120 | 4.15 |
| Japan Pharmaceutical Association website | 81 | 4.01 |
| Ehime Pharmaceutical Association website | 116 | 4.26 |
| Infectious disease-related association websites | 38 | 4.24 |
| Japan Pharmaceutical and Medical Devices Agency | 19 | 4.06 |
| YouTube and other social networking video services | 21 | 3.53 |
| Academic research papers on PubMed, etc. | 2 | 5.00 |
| Other | 15 | 4.07 |
n = 174 (multiple answers allowed)